189 related articles for article (PubMed ID: 9203663)
21. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
Liaw SJ; Wu HC; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
[TBL] [Abstract][Full Text] [Related]
22. [In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates].
Sánchez A; Escandón P; Castañeda E
Rev Iberoam Micol; 2008 Sep; 25(3):145-9. PubMed ID: 18785782
[TBL] [Abstract][Full Text] [Related]
23. Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans.
Hoffman HJ; McClelland EE
Methods Mol Biol; 2024; 2775():269-275. PubMed ID: 38758324
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.
Chan MY; Tay ST
Mycoses; 2010 Jan; 53(1):26-31. PubMed ID: 19389064
[TBL] [Abstract][Full Text] [Related]
25. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)].
Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B
Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
27. Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line.
Ganendren R; Carter E; Sorrell T; Widmer F; Wright L
Microbes Infect; 2006 Apr; 8(4):1006-15. PubMed ID: 16487740
[TBL] [Abstract][Full Text] [Related]
28. [Urease activity in Cryptococcus neoformans and Cryptococcus gattii].
Torres-Rodríguez JM; Alvarado-Ramírez E; Gutiérrez-Gallego R
Rev Iberoam Micol; 2008 Mar; 25(1):27-31. PubMed ID: 18338924
[TBL] [Abstract][Full Text] [Related]
29. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
Chayakulkeeree M; Sorrell TC; Siafakas AR; Wilson CF; Pantarat N; Gerik KJ; Boadle R; Djordjevic JT
Mol Microbiol; 2008 Aug; 69(4):809-26. PubMed ID: 18532984
[TBL] [Abstract][Full Text] [Related]
30. Evidence implicating phospholipase as a virulence factor of Candida albicans.
Ibrahim AS; Mirbod F; Filler SG; Banno Y; Cole GT; Kitajima Y; Edwards JE; Nozawa Y; Ghannoum MA
Infect Immun; 1995 May; 63(5):1993-8. PubMed ID: 7729913
[TBL] [Abstract][Full Text] [Related]
31. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.
Kwon-Chung KJ; Wickes BL; Booth JL; Vishniac HS; Bennett JE
Infect Immun; 1987 Aug; 55(8):1751-4. PubMed ID: 3112009
[TBL] [Abstract][Full Text] [Related]
32. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
Anderson DA; Sagha HM
Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
[TBL] [Abstract][Full Text] [Related]
33. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system.
Jain N; Li L; McFadden DC; Banarjee U; Wang X; Cook E; Fries BC
Infect Immun; 2006 Feb; 74(2):896-903. PubMed ID: 16428732
[TBL] [Abstract][Full Text] [Related]
35. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
36. Cryptococcus neoformans variety gattii.
Sorrell TC
Med Mycol; 2001 Apr; 39(2):155-68. PubMed ID: 11346263
[TBL] [Abstract][Full Text] [Related]
37. Ethanolic Extract Propolis-Loaded Niosomes Diminish Phospholipase B1, Biofilm Formation, and Intracellular Replication of
Kietrungruang K; Sookkree S; Sangboonruang S; Semakul N; Poomanee W; Kitidee K; Tragoolpua Y; Tragoolpua K
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687052
[TBL] [Abstract][Full Text] [Related]
38. Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii.
Sánchez M; Colom F
Rev Iberoam Micol; 2010 Mar; 27(1):10-3. PubMed ID: 20167522
[TBL] [Abstract][Full Text] [Related]
39. Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA).
Santangelo RT; Chen SC; Sorrell TC; Wright LC
Med Mycol; 2005 Jun; 43(4):335-41. PubMed ID: 16110779
[TBL] [Abstract][Full Text] [Related]
40. Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties.
Banno Y; Yamada T; Nozawa Y
Sabouraudia; 1985 Feb; 23(1):47-54. PubMed ID: 3887602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
